GEODE CAPITAL MANAGEMENT, LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1214717
BOSTON, MA
Position in TEVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$318,217,437
-$4,072,752 QoQ
Shares Held
10,564,988
+2.3% QoQ
Ownership
0.907%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,630,059,403 across 67 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
11,349,248 | $1,341,594,605 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,233,029 | $731,161,535 | |
| 3 | VTRS |
Viatris Inc
|
31,846,107 | $430,240,905 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
10,564,988 | $318,217,437 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,136,672 | $281,485,168 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,192,404 | $267,834,227 | |
| 7 | ALKS |
Alkermes plc.
|
4,182,267 | $147,884,960 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,765,952 | $133,947,458 |
All Filings in TEVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $318,217,437 | 10,564,988 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $322,290,189 | 10,326,504 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $201,795,474 | 9,989,875 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $161,390,855 | 9,629,526 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $141,321,124 | 9,194,608 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $204,554,386 | 9,281,052 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $158,432,037 | 8,792,011 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $138,139,413 | 8,500,887 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $114,329,407 | 8,102,722 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $81,212,603 | 7,778,985 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $76,456,945 | 7,495,779 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $53,813,890 | 7,146,599 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $59,760,173 | 6,752,562 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $59,694,057 | 6,545,401 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $53,529,229 | 6,633,114 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $47,514,360 | 6,318,399 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $57,165,334 | 6,087,895 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $47,494,510 | 5,929,402 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $55,729,143 | 5,721,678 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $51,356,933 | 5,187,569 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $54,254,859 | 4,701,461 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $47,382,513 | 4,910,105 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $39,011,488 | 4,329,799 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $53,293,453 | 4,322,259 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $38,485,594 | 4,285,701 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||